Home Newsfeeds BMO Capital Downgrades Universal Health Services to Underperform, Announces $90 Price Target

BMO Capital Downgrades Universal Health Services to Underperform, Announces $90 Price Target

BMO Capital analyst Matt Borsch downgrades Universal Health Services (NYSE:UHS) from Market Perform to Underperform and announces $90 price target.

byBenzinga Newsdesk

July 6, 2022

1 minute read

BMO Capital analyst Matt Borsch downgrades Universal Health Services (NYSE:UHS) from Market Perform to Underperform and announces $90 price target.

Analyst Ratings

Analyst Ratings For Chewy

By Benzinga Insights

January 11, 8:00 AM

In the last three months, 17 analysts have published ratings on Chewy (NYSE:CHWY), offering a diverse range of…

CHWY

EF Hutton Initiates Coverage On CareCloud with Buy Rating, Announces Price Target of $8.5

By Benzinga Newsdesk

March 20, 10:38 AM

EF Hutton analyst Constantine Davides initiates coverage on CareCloud (NASDAQ:CCLD) with a Buy rating and announces Price Target of $8.5.

CCLD

DNA Medicine Focused INOVIO Pharma Efficiencies Implemented By Leadership Will Help De-Risk Its Platform Technology: Analyst

By Vandana Singh

May 14, 2:37 PM

Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase 1/2 trials for Accelerated Approval. Potential as the first non-surgical RRP treatment.

INO

Credit Suisse Reports CHF 61.2B Withdrawal In Final Quarterly Earnings Ahead Of UBS Takeover

By Vandana Singh

April 24, 6:33 AM

On Monday, Credit Suisse Group Inc (NYSE:CS) reported Q1 FY23 earnings, probably the final of its 167-year history. The longtime second-largest bank…

BMO Capital Downgrades Universal Health Services to Underperform, Announces $90 Price Target

Related Posts

Analyst Ratings For Chewy

EF Hutton Initiates Coverage On CareCloud with Buy Rating, Announces Price Target of $8.5

DNA Medicine Focused INOVIO Pharma Efficiencies Implemented By Leadership Will Help De-Risk Its Platform Technology: Analyst

Credit Suisse Reports CHF 61.2B Withdrawal In Final Quarterly Earnings Ahead Of UBS Takeover